Form 4: Karin Shanahan Reports Changes in Beneficial Ownership of Bristol-Myers Squibb Co. Stock
SEC Form 4 Filing
EVP Karin Shanahan reports transactions involving Bristol-Myers Squibb common stock and restricted stock units.
Summary
- On April 1, 2024, Karin Shanahan, EVP of Global Product Development & Supply at Bristol-Myers Squibb, reported transactions involving the company's common stock and restricted stock units.
- Shanahan acquired 3,306 shares of common stock upon vesting of restricted stock units.
- 1,196 shares were withheld for payment of taxes at a price of $52.99 per share.
- Following these transactions, Shanahan directly owns 5,336 shares of common stock and indirectly owns 818.59 shares through the BMS Savings and Investment Program.
- She also directly owns 6,613 restricted stock units.
- The restricted stock units vest in four equal annual installments beginning on April 1, 2023.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing stock transactions, and carries a neutral sentiment.
Industry Context
This filing is a routine disclosure of stock transactions by a company executive, which is common practice in publicly traded companies to ensure transparency and compliance with SEC regulations.
Stakeholder Impact
- The filing provides transparency to shareholders regarding executive compensation and stock ownership.
Key Dates
| Date | Description |
|---|---|
| 04/01/2023 | Start date for the four equal annual installments of restricted stock units vesting. |
| 04/01/2024 | Date of the reported transactions: acquisition of stock and withholding for taxes. |
| 04/01/2026 | Expiration date of the restricted stock units. |
| 04/02/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.